“I believed in the power of PhysioPD when I first saw it twenty-five years ago, I’ve had a passion for it ever since, and now we have enough experience that I know it works.”
—Ron Beaver, PhD, Founder

About Rosa & Co

Rosa was founded in 2002 and remains an employee-owned, science-focused, and client-friendly firm. Today, Rosa is the worldwide commercial leader in PhysioPD-style Research, with comprehensive basic biology and therapeutic experience, industry-leading modeling expertise, and repeat research engagements with a majority of the Top 20 pharmaceutical companies.

Rosa's ForecastMD Platforms, which offers a credible methodology for determining expected physician uptake for healthcare products, was started by Bill Brastow, Ph.D., in 2005. Our models have helped shape first-in-class markets including novel therapy combinations for HIV and molecular diagnostic tests for Oncology.

Rosa’s staff bring more than a century of aggregate experience in applying modeling to the inherent challenges faced by drug developers and have authored hundreds of scientific posters, conference presentations, relevant patents, and peer-reviewed publications.

Recent Highlights

Rosa to attend the MarcusEvans Evolution Summit

Meet with Matt Marano, Chief Commercial Officer of Rosa & Co., to learn more about Rosa’s PhysioPD® Research Platforms at the MarcusEvans Evolution Summit in Montreux, Switzerland, on April 20-21, 2023. For more information about the summit, see ... Read More

Apply for Rosa’s Early Career Investigator Webinars

Rosa is seeking PhD students, postdoctoral scholars, and early researchers in academia & industry to present as part of the Rosa World Wide Webinar series. These webinars will support outstanding early career investigators by providing an opportu... Read More

Rosa & Co. announces the publication of an article on modeling in cancer immunotherapy

Rosa & Co. announced today the publication of an article titled, “From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology (QSP) Modeling in Cancer Immunotherapy,” which was published online ahead of p... Read More

The Rosa & Co. Executive Team